MolNFT v1 · #58663 · protein
Structural basis for the inhibition of bacterial NAD+ dependent DNA ligase
3BAB: “Structural basis for the inhibition of bacterial NAD+ dependent DNA ligase”. X-ray diffraction, 3 ligands (NMN, 3BD, SO4), 4 pockets (best druggability 0.72). MolNFT v1 #58663 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 3BAB
- Type
- protein
- Length
- 312 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- DNA ligase
- EC
- 6.5.1.2
- UniProt
- Q837V6
- Ligands
- NMN, 3BD, SO4
- Pockets
- 4 · best druggability 0.72
Structure
x-ray diffraction · 1 distinct chain · 41% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | DNA ligase (EC 6.5.1.2) | protein | 312 | 41% helix, 23% strand | Q837V6 |
Ligands and binding sites
- NMN · Beta-nicotinamide ribose monophosphate · ligand · chains A
- 3BD · 7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide · ligand · chains A
- SO4 · Sulfate ion · ion · 4 copies · chains A
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 463 | 0.72 | 0.82 | 47 | 3BD |
| 2 | 202 | 0.57 | 0.80 | 33 | GOL |
| 3 | 63 | 0.40 | 0.80 | 17 | NMN |
| 4 | 83 | 0.34 | 0.75 | 27 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q837V6
- Elsewhere: RCSB PDB 3BAB · PDBe 3BAB · UniProt Q837V6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.